Medical Policy updates
Approved new or revised Medical Policies and their effective dates are posted on our website the first day of each month. These policies may impact your reimbursement and your patients’ benefits. You may view all active and pending Policies or view draft Medical Policies and comment.

While information on new or revised Medical Policies is also published in this newsletter for your convenience, please visit our website for access to the most complete and up-to-date Medical Policy information. If you have any questions about BCBSNM’s Medical Policies, please call Health Services at (505) 816-2093.


Effective Date

Policy Number

Policy Name

4/1/10

SUR703.001

Organ and Tissue Transplantation (General Donor and Recipient Information)

4/1/10

SUR703.002

Stem-Cell Reinfusion or Transplantation Following Chemotherapy (General Donor and Recipient Information)

4/1/10

SUR703.029

Stem-Cell Transplant for Treatment of Chronic Lymphocytic Leukemia and Small Lymphocytic Lymphoma

4/1/10

SUR703.030

Stem-Cell Transplant for Multiple Myeloma

4/1/10

SUR703.031

Stem-Cell Transplant for Non-Hodgkin Lymphomas

4/1/10

SUR703.032

Stem-Cell Transplant for Myelodysplastic Syndromes and Myeloproliferative Diseases

4/1/10

SUR703.033

Stem-Cell Transplant for Genetic Diseases and Acquired Anemias

4/1/10

SUR703.034

Stem-Cell Transplant for Epithelial Ovarian Cancer

4/1/10

SUR703.035

Stem-Cell Transplant for Miscellaneous Solid Tumors in Adults

4/1/10

SUR703.036

Stem-Cell Transplant for Autoimmune Disorders

4/1/10

SUR703.037

Stem-Cell Transplant for Acute Myelogenous Leukemia

4/1/10

SUR703.038

Stem-Cell Transplant for Breast Cancer

4/1/10

SUR703.039

Stem-Cell Transplant for Primitive Neuroectodermal Tumors (PNET) of the CNS and Ependymoma

4/1/10

SUR703.040

Stem-Cell Transplant for Hodgkin Lymphoma

4/1/10

SUR703.041

Stem-Cell Transplant for Chronic Myelogenous Leukemia

4/1/10

SUR703.042

Stem-Cell Transplant for Astrocytomas and Gliomas

4/1/10

SUR703.043

Stem-Cell Transplant for Acute Lymphocytic Leukemia (ALL)

4/1/10

SUR703.044

Stem-Cell Transplant for Solid Tumors in Children

4/1/10

SUR703.045

Stem-Cell Transplant for Germ Cell Tumors

4/1/10

SUR703.046

Stem-Cell Transplant for Primary Amyloidosis and Waldenstroms Macroglobulinemia

4/1/10

SUR703.047

Stem-Cell Transplant for Acquired Immunodeficiency Syndrome (AIDS)

 

Blue Review • February 2010 • www.bcbsnm.com